Source: International Congress 2019 – Understanding, monitoring and targeting severe asthma
Disease area: Airway diseases, Paediatric lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
E. Herrera Luis (La Laguna, Spain), J. Perez-Garcia (La Laguna, Spain), N. Hernandez-Pacheco (La Laguna, Spain), S. Huntsman (San Francisco, United States of America), C. Eng (San Francisco, United States of America), E. Burchard (San Francisco, United States of America), F. Lorenzo-Diaz (La Laguna, Spain), M. Pino-Yanes (Madrid, Spain). A polymorphism in DNASE1L3 is associated with severe asthma exacerbations in two-high risk populations for asthma. 531

Member's Comments

No comment yet.

Related content which might interest you: COPD patients with asthma, characteristics and risk of exacerbations Source: International Congress 2019 – Multimorbidity in airway diseases and appropriate inhaled corticosteroid use in COPD Year: 2019 Prediction of the risk of future exacerbations in patients with severe persistent allergic asthma Source: Annual Congress 2005 - Severe asthma: perception and management Year: 2005 Factors associated with frequent exacerbations in patients with severe asthma Source: Eur Respir J 2001; 18: Suppl. 33, 369s Year: 2001 IFNL3 polymorphisms are associated with COPD severity and outcomes Source: International Congress 2017 – Towards personalised medicine in COPD: biological and clinical phenotypes Year: 2017 Genetic comparison between severe persistent asthma and COPD Source: Eur Respir J 2003; 22: Suppl. 45, 81s Year: 2003 Increasing risk of exacerbation and mortality associated with increasing frequency and severity of exacerbations in COPD patients: EXACOS-UK Source: Virtual Congress 2021 – Prediction of exacerbations in patients with COPD Year: 2021 The risk of hyperkalemia in COPD and asthma patients Source: International Congress 2019 – Phenotypes and comorbidities of airway diseases Year: 2019 Specific comorbidities and low adherence are independent risk factors for poorer asthma control and exacerbations in patients with difficult-to-control asthma Source: International Congress 2019 – Long-term evaluation and control of airway diseases Year: 2019 Rates of asthma exacerbations are not affected by beta2-adrenergic receptor genotype in patients with persistent asthma Source: Eur Respir J 2005; 26: Suppl. 49, 708s Year: 2005 Are COPD exacerbations associated with the severity of the disease? Source: Eur Respir J 2005; 26: Suppl. 49, 300s Year: 2005 A high-risk airway mycobiome is associated with frequent exacerbation and mortality in COPD Source: Eur Respir J, 57 (3) 2002050; 10.1183/13993003.02050-2020 Year: 2021 Predicting persistent disease among children who wheeze during early life Source: Eur Respir J 2003; 22: 767-771 Year: 2003 Differential dropout may affect exacerbation risk estimates differently in moderate-to-very severe COPD Source: Annual Congress 2012 - Trials in COPD: novel treatments and insights Year: 2012 Distribution of biomarkers in severe asthma and severe uncontrolled asthma Source: Virtual Congress 2021 – Pearls in asthma and respiratory burden research Year: 2021 Exacerbations in severe persistent asthma - impact of risk factors control Source: Eur Respir J 2005; 26: Suppl. 49, 683s Year: 2005 Risk factors for severe exacerbations in a real-life population of adults with severe refractory asthma Source: International Congress 2017 – Many faces of asthma and allergies Year: 2017 Risk factors for severe exacerbations in asthma Source: Eur Respir J 2002; 20: Suppl. 38, 199s Year: 2002 Frequency and clinical characteristics of rapid-onset fatal and near-fatal asthma Source: Eur Respir J 2002; 19: 846-852 Year: 2002 The median number of COPD exacerbations per year in patients with different polymorphisms of the gene ADRB2 Source: International Congress 2015 – Notable abstracts in exacerbations, mechanisms and biomarkers in COPD Year: 2015 Chronic bronchitis, asthma and rhinitis are differently associated with cardiovascular risk factors and diseases. Source: International Congress 2017 – Asthma epidemiology among children and adults: from biomarkers to ACOS Year: 2017